Storyline

New frameworks advance genetics-informed drug target prioritization and brain receptor mapping

Recent advances highlight two complementary approaches to improve drug development for neurological disorders.

Evidence locked
Today's free sample is only available for the edition's flagship storyline.
Evidence preview
  • arXiv q-bio (new submissions)
    arxiv.org
  • bioRxiv (all subjects)
    biorxiv.org